Improvement of Vascular Insulin Sensitivity by Ranolazine

Ranolazine (RN) is a drug used in the treatment of chronic coronary ischemia. Different clinical trials have shown that RN behaves as an anti-diabetic drug by lowering blood glucose and glycosylated hemoglobin (HbA1c) levels. However, RN has not been shown to improve insulin (IN) sensitivity. Our st...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerra-Ojeda, Sol, Jorda, Adrian, Aldasoro, Constanza, Vila, Jose M., Valles, Soraya L., Arias-Mutis, Oscar J, Aldasoro, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487645/
https://www.ncbi.nlm.nih.gov/pubmed/37686345
http://dx.doi.org/10.3390/ijms241713532